Concepedia

A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker

Leila Khoja, Alison Backen, Robert Szczepaniak‐Sloane, Lia P. Menasce, Matthew Krebs, Ruth Board, Glen Clack, Andrew Hughes, Fiona Blackhall, Juan W. Valle,

British Journal of Cancer · 2011 · 252 citations · 35 references

DOIFull text

Open access

Abstract

ISET detects more CTCs than CellSearch and offers flexible CTC characterisation with potential to investigate CTC biology and develop biomarkers for pancreatic cancer patient management.

References

35

FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer

Thierry Conroy, Françoise Desseigne, Marc Ychou et al. · New England Journal of Medicine · 2011 · 7.6K citations · Full text

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.

Howard A. Burris, Malcolm J. Moore, John Sahl Andersen et al. · Journal of Clinical Oncology · 1997 · 5.8K citations

Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer

Massimo Cristofanilli, G. Thomas Budd, Matthew J. Ellis et al. · New England Journal of Medicine · 2004 · 4.5K citations · Full text

Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group

Malcolm J. Moore, David Goldstein, John Hamm et al. · Journal of Clinical Oncology · 2007 · 3.8K citations

Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant Diseases

W. Jeffrey Allard, Jeri Matera, Michael Craig Miller et al. · Clinical Cancer Research · 2004 · 2.5K citations